Hidden Dangers in E-Cigarette Products: A Health Hazard

Aug.08.2024
Hidden Dangers in E-Cigarette Products: A Health Hazard
Duke University researchers reveal tobacco companies substituting unknown, potentially harmful chemicals for nicotine in e-cigarettes to avoid regulations.

According to Mirage News on August 8th, health researchers at Duke University in North Carolina reported that some tobacco companies have started using alternative chemicals with similar characteristics but unknown health impacts to replace nicotine in e-cigarette products in order to circumvent public health regulations.


In a research letter published in the Journal of the American Medical Association on August 7th, researchers from Duke University and Yale University also found that the quantities of these chemicals (known as nicotine analogs) were not accurately disclosed on the packaging.


The study's co-author, Senior Research Scientist Sairam V. Jabba, D.V.M., Ph.D., of Duke University School of Medicine, stated that...


E-cigarette products containing nicotine are restricted by federal law, prohibiting sales to individuals under the age of 21.


Currently, nicotine analogs are not restricted by FDA regulations, and their health effects have not been studied. Our analysis of some e-cigarette products containing analogs sold in the United States found significant and concerning discrepancies between the claimed ingredients and the actual ingredients. Furthermore, manufacturers may be trying to circumvent FDA tobacco regulation.


The study emphasizes that a chemical compound called 6-methyl nicotine is shown in rodent experiments to be more effective and more toxic than nicotine in targeting brain nicotine receptors. Another chemical compound called nicotinamide is advertised as targeting the same brain receptors, although evidence suggests it does not bind to these receptors.


These nicotine analogs are added to flavored e-cigarettes, previous studies have shown that these e-cigarettes are more popular among young people and first-time e-cigarette users.


Jabba and colleagues, including co-senior author Sven Eric Jordt, Ph.D., analyzed a e-cigarette product called Spree Bar, which has at least nine flavors and is labeled as containing 5% 6-methylnicotine. The research findings showed that the actual chemical content was about 88% lower than what was indicated on the label. This e-cigarette also contains an artificial sweetener that is 13,000 times sweeter than sucrose, as well as an artificial cooling agent that mimics the effect of mint.


The second brand of e-cigarette (sold under the names Nixotine, Nixodine, Nixamide, and Nic-Safe) contains a nicotine analogue called niacin, with levels lower than indicated on the label, and combined with an undisclosed amount of 6-methyl nicotine. This brand does not contain any sweeteners or cooling agents.


These products appear to be designed to circumvent laws and regulations aimed at protecting people, especially children, from the harmful effects of smoking and tobacco use. We do not know what effects these chemicals may have when heated and inhaled. These questions should be answered before allowing the products to be marketed.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S FDA Announces Dec. 8 Deadline for IQOS MRTP Renewal Comments
U.S FDA Announces Dec. 8 Deadline for IQOS MRTP Renewal Comments
The U.S. FDA has set December 8, 2025, 11:59 p.m. ET as the closing date for public comments on the MRTP renewal applications submitted by Philip Morris Products S.A. for several IQOS heated tobacco products.
Nov.07 by 2FIRSTS.ai
Maldives Implements World's First Generational Prohibition on Tobacco, Banning Sales and Smoking for Those Born After 2007
Maldives Implements World's First Generational Prohibition on Tobacco, Banning Sales and Smoking for Those Born After 2007
The Maldives has implemented a generational tobacco ban, effective November 1, 2025, making it the only country to permanently prohibit anyone born on or after January 1, 2007 from buying or using tobacco. Initiated by President Mohamed Muizzu, the policy aims to create a tobacco-free generation and includes a nationwide ban on e-cigarettes, with fines up to 50,000 rufiyaa (US$3,200) for violations.
Nov.03 by 2FIRSTS.ai
PMI Urges South Africa to Differentiate Smoke-Free Products from Cigarettes
PMI Urges South Africa to Differentiate Smoke-Free Products from Cigarettes
South Africa is drafting new tobacco legislation aimed at reducing smoking-related deaths and promoting harm reduction.PMI said smoke-free products such as nicotine pouches and heated devices could play a critical role in reducing harm. Patrik Hildingsson, PMI’s director for oral products communications, said South Africa is developing a new regulatory framework to recognise and regulate smoke-free products, calling it a “big change” for the industry.
Oct.22 by 2FIRSTS.ai
JT Partners with Japan’s Year-End Music Festivals, Unveils Eight Limited-Edition Ploom AURA Front Panels
JT Partners with Japan’s Year-End Music Festivals, Unveils Eight Limited-Edition Ploom AURA Front Panels
Japan Tobacco Inc. (JT) will partner with two major year-end music festivals in Japan to set up “Ploom LOUNGE” smoking areas on-site, offering trial experiences of its Ploom AURA heated tobacco device. The company will also launch eight festival-exclusive front panels for Ploom AURA, distributed through on-site exchanges and a member lottery program.
Dec.11 by 2FIRSTS.ai
Australian Border Force Seizes 586M Cigarettes and 3M Vapes in Record First Quarter
Australian Border Force Seizes 586M Cigarettes and 3M Vapes in Record First Quarter
Australian Border Force (ABF), 586 million cigarettes and over 3 million vapes were seized at Australia’s international border in the first quarter of the 2024–25 financial year (July 1–September 30), marking a continued upward trend over the past two years. Enhanced intelligence and data-sharing have enabled ABF to target suspicious consignments more effectively across all entry points.
Oct.24 by 2FIRSTS.ai
CSUR, the Research Institute Supporting Juul’s PMTA Research, Outlines a New Pathway for Nicotine Pouches
CSUR, the Research Institute Supporting Juul’s PMTA Research, Outlines a New Pathway for Nicotine Pouches
CSUR—the Research Institute Supporting Juul and NJOY’s successful PMTAs—assessed FDA’s pilot for nicotine pouches. The program expedites premarket review by deferring behavioral data to post-market reporting. CSUR says this could speed authorizations, but manufacturers must still produce behavioral and real-world evidence after a Marketing Granted Order to maintain compliance with public-health standards.
Nov.04